Bio-Rad Laboratories Inc (Bio-Rad) manufactures and distributes life science research and clinical diagnostics products. The company's product portfolio includes antibodies, autoimmune testing kits, blood typing and antibody detection systems, cell isolation and analysis tools, and digital PCR, among others. The company serves to various markets including life science research, healthcare, analytical chemistry, and other markets. Bio-Rad’s products find applications in bioprocess analytics, cell research, gene expression analysis, immunology, and mutation detection, among others. It markets products through a direct sales force and a network of distributors, agents, brokers, and resellers worldwide. The company operates in the US, Canada, Latin America, Europe and Asia, among others. Bio-Rad Laboratories Inc is headquartered in Hercules, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Bio-Rad Laboratories Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Bio-Rad Laboratories Inc Company Overview
- Bio-Rad Laboratories Inc Company Snapshot
- Bio-Rad Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview
- Bio-Rad Laboratories Inc - Pipeline Analysis Overview
- Business Description
- Bio-Rad Laboratories Inc - Key Facts
- Bio-Rad Laboratories Inc - Major Products and Services
- Bio-Rad Laboratories Inc Pipeline Products by Development Stage
- Bio-Rad Laboratories Inc Pipeline Products Overview
- Biomeprint
- Biomeprint Product Overview
- BioPlex 2200 - Gastrointestinal Disease Test
- BioPlex 2200 - Gastrointestinal Disease Test Product Overview
- BioPlex 2200 - Hepatitis Test
- BioPlex 2200 - Hepatitis Test Product Overview
- Droplet Digital PCR - MRSA Infection
- Droplet Digital PCR - MRSA Infection Product Overview
- Gene Based Blood Test - Melanoma
- Gene Based Blood Test - Melanoma Product Overview
- Genetic Panel - SCD
- Genetic Panel - SCD Product Overview
- Imaging-And-Microfluidics Chip
- Imaging-And-Microfluidics Chip Product Overview
- Multiplexed Mutation Detection Assay - Cancer Monitoring
- Multiplexed Mutation Detection Assay - Cancer Monitoring Product Overview
- Multiplexed Mutation Detection Assay - Therapy Selection
- Multiplexed Mutation Detection Assay - Therapy Selection Product Overview
- PCR|ONE - Respiratory Panel
- PCR|ONE - Respiratory Panel Product Overview
- PCR|ONE - STI Panel
- PCR|ONE - STI Panel Product Overview
- PCR|ONE System
- PCR|ONE System Product Overview
- PCR|ONE System - Clostridium Panel
- PCR|ONE System - Clostridium Panel Product Overview
- PCR|ONE System - SARS-CoV-2 Panel
- PCR|ONE System - SARS-CoV-2 Panel Product Overview
- QX Continuum Droplet Digital PCR System
- QX Continuum Droplet Digital PCR System Product Overview
- Bio-Rad Laboratories Inc - Key Competitors
- Bio-Rad Laboratories Inc - Key Employees
- Bio-Rad Laboratories Inc - Key Employee Biographies
- Bio-Rad Laboratories Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Bio-Rad Laboratories Inc, Recent Developments
- May 22, 2024: GCCL Leverages ddPCR to Enhance Gene/cell Therapy Clinical Trial Services
- Apr 11, 2024: Bio-Rad and Allegheny Health Network Cancer Institute Partner to Advance Personalized Monitoring of Solid Tumor Cancers with Droplet Digital PCR
- Apr 03, 2024: Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research
- Apr 01, 2024: Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research
- Mar 26, 2024: Bio-Rad Launches Celselect Slides Validated Antibodies for Rare Cell and Circulating Tumor Cell Enumeration
- Feb 27, 2024: Bio-Rad Launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for Cell and Gene Therapy Production
- Jan 02, 2024: Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
- Oct 05, 2023: Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development
- Sep 28, 2023: Bio-Rad Launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers
- Aug 29, 2023: Bio-Rad Launches First StarBright Red Dye and Extends Range of Antibody Markers Conjugated to StarBright Dyes to Enhance Multiplex Flow Cytometry and Research Capabilities
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Bio-Rad Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview
- Bio-Rad Laboratories Inc Pipeline Products by Equipment Type
- Bio-Rad Laboratories Inc Pipeline Products by Indication
- Bio-Rad Laboratories Inc, Key Facts
- Bio-Rad Laboratories Inc, Major Products and Services
- Bio-Rad Laboratories Inc Number of Pipeline Products by Development Stage
- Bio-Rad Laboratories Inc Pipeline Products Summary by Development Stage
- Biomeprint - Product Status
- Biomeprint - Product Description
- BioPlex 2200 - Gastrointestinal Disease Test - Product Status
- BioPlex 2200 - Gastrointestinal Disease Test - Product Description
- BioPlex 2200 - Hepatitis Test - Product Status
- BioPlex 2200 - Hepatitis Test - Product Description
- Droplet Digital PCR - MRSA Infection - Product Status
- Droplet Digital PCR - MRSA Infection - Product Description
- Gene Based Blood Test - Melanoma - Product Status
- Gene Based Blood Test - Melanoma - Product Description
- Genetic Panel - SCD - Product Status
- Genetic Panel - SCD - Product Description
- Imaging-And-Microfluidics Chip - Product Status
- Imaging-And-Microfluidics Chip - Product Description
- Multiplexed Mutation Detection Assay - Cancer Monitoring - Product Status
- Multiplexed Mutation Detection Assay - Cancer Monitoring - Product Description
- Multiplexed Mutation Detection Assay - Therapy Selection - Product Status
- Multiplexed Mutation Detection Assay - Therapy Selection - Product Description
- PCR|ONE - Respiratory Panel - Product Status
- PCR|ONE - Respiratory Panel - Product Description
- PCR|ONE - STI Panel - Product Status
- PCR|ONE - STI Panel - Product Description
- PCR|ONE System - Product Status
- PCR|ONE System - Product Description
- PCR|ONE System - Clostridium Panel - Product Status
- PCR|ONE System - Clostridium Panel - Product Description
- PCR|ONE System - SARS-CoV-2 Panel - Product Status
- PCR|ONE System - SARS-CoV-2 Panel - Product Description
- QX Continuum Droplet Digital PCR System - Product Status
- QX Continuum Droplet Digital PCR System - Product Description
- Bio-Rad Laboratories Inc, Key Employees
- Bio-Rad Laboratories Inc, Key Employee Biographies
- Bio-Rad Laboratories Inc, Subsidiaries
- Glossary
- Bio-Rad Laboratories Inc Pipeline Products by Equipment Type
- Bio-Rad Laboratories Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc
- Danaher Corp
- Siemens Healthineers AG
- Becton Dickinson and Co
- Abbott Laboratories
- Tosoh Corp
- F. Hoffmann-La Roche Ltd
- DiaSorin SpA
- bioMerieux SA
- Ortho Clinical Diagnostics Holdings Plc
- Immucor Inc
